Profilo
Mira Leiwant currently works at Anika Therapeutics, Inc., as Senior VP-Quality, Regulatory & Clinical Affairs.
Ms. Leiwant also formerly worked at LifeCell Corp., as Senior Director-Regulatory & Quality Engineering and BTG International, Inc., as Vice President-Regulatory Affairs.
Ms. Leiwant received her undergraduate degree in 1997 and graduate degree in 1998 from Cornell University.
Posizioni attive di Mira Leiwant
| Società | Posizione | Inizio |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 14/10/2019 |
Precedenti posizioni note di Mira Leiwant
| Società | Posizione | Fine |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Consigliere Generale | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Formazione di Mira Leiwant
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
















